Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 201-211 , August 2004

Psychometric study of quality of life instruments used during hospitalization for stem cell transplantation

  • Jesús M. Prieto

      Affiliations

    • Corresponding Author InformationCorresponding author. Centre Mèdic REMEFI, Carrer Nou 20, 17600 Figueres, Spain. Tel.: (34) 972-510411; fax: (34) 972-510411
    • Department of Psychiatry, Clinical Institute of Psychiatry and Psychology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • Department of Psychiatry, Institut d'Assistencia Sanitaria, Girona, Spain
    • ,
  • Jorge Atala

      Affiliations

    • Department of Psychiatry, Hospital Nostra Senyora de Meritxell, Andorra la Vella, Principat d'Andorra, Spain
    • ,
  • Jordi Blanch

      Affiliations

    • Department of Psychiatry, Clinical Institute of Psychiatry and Psychology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Enric Carreras

      Affiliations

    • SCT Unit, Department of Hematology, Institute of Hematology and Oncology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Montserrat Rovira

      Affiliations

    • SCT Unit, Department of Hematology, Institute of Hematology and Oncology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Esteve Cirera

      Affiliations

    • Department of Psychiatry, Clinical Institute of Psychiatry and Psychology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain
    • ,
  • Cristóbal Gastó

      Affiliations

    • Department of Psychiatry, Clinical Institute of Psychiatry and Psychology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain

Received 17 February 2003 ,Accepted 28 October 2003.

References 

  1. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant. 2001;27:899–916
  2. Lennard AL, Jackson GH. Stem cell transplantation. BMJ. 2000;321:433–437
  3. Neitzert CS, Ritvo P, Dancey J, Weiser K, Murray C, Avery J. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant. 1998;22:409–422
  4. Hjermstad MJ, Kaasa S. Quality of life in adult cancer patients treated with bone marrow transplantation—a review of the literature. Eur J Cancer. 1995;31:163–173
  5. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant. 1993;11:319–327
  6. Jenkins PL, Lester HL, Alexander J, Whittaker J. A prospective study of psychosocial morbidity in adult bone marrow transplant recipients. Psychosomatics. 1994;35:361–367
  7. Leigh S, Wilson KCM, Burns R, Clark RE. Psychosocial morbidity in bone marrow transplant recipients: a prospective study. Bone Marrow Transplant. 1995;16:635–640
  8. Andrykowski MA, Bruehl S, Brady MJ, Henslee-Downey PJ. Physical and psychosocial status of adult one-year after bone marrow transplantation: a prospective study. Bone Marrow Transplant. 1995;15:837–844
  9. McQuellon RP, Craven B, Russell GB, Hoffman S, Cruz JM, Perry JJ, et al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant. 1996;18:579–584
  10. Wettergren L, Langius A, Björkholm M, Björkholm H. Physical and psychosocial functioning in patients undergoing bone marrow transplantation—a prospective study. Bone Marrow Transplant. 1997;20:497–502
  11. Keogh F, O'Riordan J, McNamara C, Duggan C, Mc Cann SR. Psychosocial adaptation of patients and families following bone marrow transplantation: a prospective, longitudinal study. Bone Marrow Transplant. 1998;22:905–911
  12. Hjermstad MJ, Evensen SA, Kvaløy SO, Fayers PM, Kaasa S. Health-related quality of life 1 year after allogeneic or autologous stem cell transplantation: a prospective study. J Clin Oncol. 1999;17:706–718
  13. Broers S, Kaptein AA, Le Cessie S, Fibbe W, Hengeveld MW. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J Psychosom Res. 2000;48:11–21
  14. Carlson LE, Koski T, Glück S. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. Bone Marrow Transplant. 2001;27:989–998
  15. McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, et al. Quality of life and psychological distress of bone marrow transplant recipients: the “time trajectory” to recovery over the first year. Bone Marrow Transplant. 1998;21:477–486
  16. Hjermstad MJ, Loge JH, Evensen SA, Kvaløy SO, Fayers PM, Kaasa S. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant. 1999;24:1219–1228
  17. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol. 1994;12:820–826
  18. Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER. Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol. 2000;18:1539–1549
  19. Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907–1917
  20. Gillis TA, Donovan ES. Rehabilitation following bone marrow transplantation. Cancer. 2001;92(Suppl 4):998–1007
  21. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher RA, Clift RA, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562–1568
  22. Lesko LM. Bone marrow transplantation. In:  Holland JC,  Rowland JH editor. Handbook of psychooncology. New York: Oxford University Press; 1990;p. 163–173
  23. Cella D. Quality of life. In:  Holland JC editors. Psycho-oncology. New York: Oxford University Press; 1998;p. 1135–1162
  24. Phipps S, Hinds PS, Channell S, Bell GL. Measurement of behavioral, affective, and somatic responses to pediatric bone marrow transplantation: development of the BASES scale. J Pediatr Oncol Nurs. 1994;11:109–117
  25. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Scale. Bone Marrow Transplant. 1997;19:357–368
  26. Grant M, Ferrell B, Schmidt GM, Fonbuena P, Niland JC, Forman SJ. Measurement of quality of life in bone marrow transplantation survivors. Qual Life Res. 1992;1:375–384
  27. Saleh US, Brockopp DY. Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool. Oncol Nurs Forum. 2001;28:1457–1464
  28. McCabe MS. A cooperative group report on quality-of-life research: lessons learned. J Natl Cancer Inst Monogr. 1996;20:63–65
  29. Beitz J, Gnecco C, Justice R. Quality-of-life end points in cancer clinical trials: the US food and drug administration perspective. J Natl Cancer Inst Monogr. 1996;20:7–9
  30. Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncol. 2001;12(Suppl 3):3–6
  31. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol. 1999;17:2256–2263
  32. Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, et al. Association of depressive symptoms and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2218–2226
  33. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002;20:2514–2519
  34. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–3673
  35. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington (DC): American Psychiatric Association; 1994;
  36. Massie MJ, Popkin MK. Depressive disorders. In:  Holland JC editors. Psycho-oncology. New York: Oxford University Press; 1998;p. 518–540
  37. Noyes R, Holt CS, Massie MJ. Anxiety disorders. In:  Holland JC editors. Psycho-oncology. New York: Oxford University Press; 1998;p. 548–563
  38. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In:  MacLeod CM editors. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949;p. 199–205
  39. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med. 1981;15(Suppl. A):221–229
  40. Alonso J, Prieto L, Anto JM. The Spanish version of the of the Nottingham health profile: a review of adaptation and instrument characteristics. Qual Life Res. 1994;3:385–393
  41. Derogatis LR. The Psychosocial Adjustment to Illness Scale (PAIS). J Psychosom Res. 1986;30:77–91
  42. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  43. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77
  44. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38:27–43
  45. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8:33–39
  46. Andrykowski MA, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R, et al. Quality of life following bone marrow transplantation: findings from a multicentre study. Br J Cancer. 1995;71:1322–1329
  47. Prieto JM, Saez R, Carreras E, Atala J, Sierra J, Rovira M, et al. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant. 1996;17:1133–1142
  48. Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplant. 1989;4:181–186
  49. Gaston-Johansson F, Franco T, Zimmerman L. Pain and psychological distress in patients undergoing autologous bone marrow transplantation. Oncol Nurs Forum. 1992;1:41–48
  50. Lee SJ, Klar N, Weeks JC, Antin JH. Predicting costs of stem-cell transplantation. J Clin Oncol. 2000;18:64–71
  51. DeVellis RF. Scale development: theory and applications. Newbury Park (CA): Sage Publications; 1991;
  52. Nunnally JC. Psychometric theory. New York: McGraw-Hill; 1978;
  53. Fayers PM, Hand DJ. Factor analysis, causal indicators, and quality of life. Qual Life Res. 1997;6:139–150
  54. Balfour JL, Kaplan GA. Social class/socioeconomic factors. In:  Holland JC editors. Psycho-oncology. New York: Oxford University Press; 1998;p. 78–90
  55. Schulz-Kindermann F, Hennings U, Ramm G, Zander AR, Hasenbring M. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplant. 2002;29:341–351
  56. Larson PJ, Viele CS, Coleman S, Dibble SL, Cebulski C. Comparison of perceived symptoms of patients undergoing bone marrow transplant and the nurses caring for them. Oncol Nurs Forum. 1993;20:81–88
  57. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998;16:3662–3673
  58. Bernhard J, Sullivan M, Hürny C, Coates AS, Rudenstam CM. Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer. 2001;84:1156–1165
  59. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet. 1999;354:816–819
  60. Coates A, Glasziou P, McNeil D. On the receiving end–III. Measurement of quality of life during cancer chemotherapy. Ann Oncol. 1990;1:213–217

PII: S0022-3999(04)00050-9

doi: 10.1016/j.jpsychores.2003.10.015

Journal of Psychosomatic Research
Volume 57, Issue 2 , Pages 201-211 , August 2004

Article Tools

* Image Usage & Resolution